Platelet-derived growth factor receptor alpha — Drug Target

All drugs that target Platelet-derived growth factor receptor alpha — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Platelet-derived Growth Factor Receptor alpha Antagonist · Kinase Inhibitor [EPC]

Marketed (2)

• Lartruvo · Eli Lilly · Platelet-derived Growth Factor Receptor alpha Antagonist · Oncology
• Ayvakit · Blueprint Medicines · Kinase Inhibitor [EPC] · Oncology
  Ayvakit works by blocking the activity of the PDGFRA protein, which is involved in the growth and spread of cancer cells.